🔓
Sign in as a Member to unlock the full view of ADCT. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
ADCT

ADC Therapeutics S.A.

Sector: healthcareBiotechnologyNYSEMarket Cap: $507.9M

ADC Therapeutics S.A. is a clinical-stage oncology company developing antibody-drug conjugates, with a dominant political signal being $4.6M in concentrated insider buys by a single investment firm in early 2024.

Next filing → your inbox
Govt Dependence
0/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat ADCT does

ADC Therapeutics S.A. is a clinical-stage biotechnology company focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its lead product, ZYNLONTA (loncastuximab tesirine-lpyl), is a CD19-directed ADC approved for relapsed or refractory diffuse large B-cell lymphoma. The company's revenue is primarily derived from ZYNLONTA sales and collaboration agreements.

12 months past · 3 months futureADCT activity timeline

$5$3$1 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $4.88 hi $0.96 lo $1.25 CONGRESS 2 INSIDERS 0 13F FUNDS 29 BILLS 30 Point72 Asset Management · OPENED $13M · 2026-03-31Point72 Asset Management · + $4M · 2026-06-30Two Sigma Investments · + $3M · 2026-03-31Citadel Advisors · + $2M · 2026-06-30Citadel Advisors · + $1M · 2026-03-31Renaissance Technologies · OPENED $1M · 2026-03-31Citadel Advisors · - $1M · 2025-12-31D.E. Shaw & Co. · + $1M · 2026-03-31AQR Capital Management · OPENED $1M · 2026-03-31Two Sigma Investments · + $1M · 2026-06-30D.E. Shaw & Co. · + $1M · 2026-06-30D.E. Shaw & Co. · OPENED $1M · 2025-12-31AQR Capital Management · + $1M · 2026-06-30Renaissance Technologies · OPENED · 2026-09-30Two Sigma Investments · + · 2025-12-31 HR.41 · passed_one · 2026-06-03HR.184 · reported · 2026-09-15HR.210 · committee · 2026-05-20HR.109 · committee · 2025-12-19 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 0 insider buys · 15 13F filings · 4 past bill actions · 5 upcoming markups

Lifetime Government AwardsADCT federal contracts

ADCT doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ADCT

$8.9M
Total ADCT held by tracked 13F funds
6
Funds with ADCT positions
+1
Funds opened this quarter
Point72 Asset Management $4M +8% 2026-06-30
Citadel Advisors $2M +414% 2026-06-30
Two Sigma Investments $828K +16% 2026-06-30
D.E. Shaw & Co. $770K +196% 2026-06-30
AQR Capital Management $704K +177% 2026-06-30
Renaissance Technologies $469K opened 2026-09-30

Politicians Trading ADCTMembers of Congress with recent ADCT positions

1 politicians traded ADCT across 2 disclosed transactions totaling $16K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ADCT). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading ADCT

2025-02-20 Ashley Moody R-Florida · senate sale $1,001 - $15,000
2025-02-20 Ashley Moody R-Florida · senate Sale (Full) $1,001 - $15,000
2+ trades on file · most recent 2025-03-22

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

4
stock awards · $1.4M market value
2026-06-30 MALLIK AMEET Chief Executive Officer AWARD 675,000 sh $722K
2026-06-30 GRAHAM PETER J Chief Legal Officer AWARD 221,100 sh $237K
2026-06-30 Zaki Mohamed Chief Medical Officer AWARD 213,900 sh $229K
2026-06-30 Carmona Jose Chief Financial Officer AWARD 203,700 sh $218K
For ADCT, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting ADCTLive legislation impacting this stock

Political ProfileWhere ADCT sits in Washington

[object Object]

STRUCTURAL: No federal contracts (get_government_precedent.federal_contracts_summary is null), $0 lobbying spend (get_political_influence.lobbying.total_income: 0), and no congressional trading (Top congressional traders array empty). EVIDENTIARY: A single investment firm, Redmile Group, executed 10 Form 4 purchases totaling ~$4.6M in Q1 2024 (Recent corp insider Form 4 buys). Net: Strong evidentiary cluster from a single non-executive entity is offset by a complete absence of structural political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA regulatory review and post-marketing requirements for ZYNLONTA.
    U.S. Food and Drug Administration (FDA)
    "Inferred from primary industry (Pharmaceuticals) and sector (Healthcare); no direct bill impacts found in Recent bill_impacts array."

Regulatory opportunities

  • FDA approval for label expansions or new indications for pipeline ADCs.
    U.S. Food and Drug Administration (FDA)
    "Inferred from business description as a clinical-stage oncology company; no direct bill carveouts found in Recent bill_carveouts array."
Member intelligence layer

Live signals + predictions for ADCT — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout ADCT & political exposure

Does ADC Therapeutics S.A. (ADCT) hold federal contracts?
No direct prime contracts reported in USASpending.gov for ADC Therapeutics S.A.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded ADCT stock?
2 congressional trades by 1 unique members of Congress, most recently on 2025-02-20. See the Congressional Trading panel for politician-by-politician breakdown.
What is ADCT political risk profile?
Government dependence: 0/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track ADCT political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ADCT data is updated daily from these official federal sources.